|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 14, 2023 |
Title |
HL60_COMBO_2 |
Sample type |
SRA |
|
|
Source name |
hematopoetic
|
Organism |
Homo sapiens |
Characteristics |
tissue: hematopoetic cell line: HL-60 cell type: non-adherent treatment: Decitabine+Simvastatin
|
Treatment protocol |
HL-60 cells in each group (DMSO, DAC 0.5 μM, simvastatin 10 μM, and DAC+simvastatin) were harvested 36 hours after exposure to each treatment
|
Growth protocol |
HL-60 (CCL-240, ATCC) cells were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) and 1% P/S.
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA was extracted using an RNeasy Mini Kit (Qiagen), and RNA integrity and purity were checked using Agilent 2100 Bioanalyzer (Agilent Technologies). 1.0μg of total RNA was used for the construction of sequencing libraries. After mRNA enrichment using oligo(dT) beads and rRNA depletion using the Ribo-Zero Plus rRNA Depletion Kit (Illumina), cDNA was synthesized using an mRNA template and random primers, second-strand synthesis buffer, dNTPs, RNase H and DNA polymerase I. The double-stranded cDNA library was completed by “A” base ligation and sequencing adaptor ligation. The quality and quantity of these libraries were checked using Qubit 2.0 (Thermo Fisher Scientific), Agilent 2100, and quantitative PCR using the Real-time PCR Systems Step One Plus (Applied Biosystems).
|
|
|
Library strategy |
RNA-Seq |
Library source |
transcriptomic |
Library selection |
cDNA |
Instrument model |
Illumina NovaSeq 6000 |
|
|
Data processing |
Read quality was confirmed using FastQC. Sequence reads were trimmed for adaptor sequence/low-quality sequence. These reads were aligned to the GRCh38 reference genome using the HISAT2 pipeline. Transcripts per million (TPM) were calculated based on the length of the gene and the number of reads mapped to each gene. Differential expression analysis among each group was performed using the DESeq2 R package. Assembly: GRCh38 Supplementary files format and content: tab-delimited text file includes raw counts for each sample. Supplementary files format and content: tab-delimited text file includes TPM counts for each sample.
|
|
|
Submission date |
Aug 09, 2023 |
Last update date |
Aug 14, 2023 |
Contact name |
Tomohiro Yabushita |
E-mail(s) |
[email protected]
|
Organization name |
The University of Tokyo
|
Street address |
7-3-1, Hongou, Bunkyo-ku
|
City |
Tokyo |
ZIP/Postal code |
113-8654 |
Country |
Japan |
|
|
Platform ID |
GPL24676 |
Series (1) |
GSE240439 |
Mitotic perturbation is a key mechanism of action of decitabine in myeloid tumor treatment |
|
Relations |
BioSample |
SAMN36905477 |
SRA |
SRX21310551 |
Supplementary data files not provided |
SRA Run Selector |
Raw data are available in SRA |
Processed data are available on Series record |
|
|
|
|
|